Inventia

3 known investors

Inventia Life Science provides advanced 3D cell culture platforms and reproducible 3D cell models for drug discovery, cancer research, and toxicology assessment. The platform, RASTRUM, generates standardized, biologically relevant cellular systems that support decision-grade data for pharmaceutical development and research teams.